Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

M.H.J. van Oers; M. van Glabbeke; L. Giurgea; R. Klasa; R.E. Marcus; M. Wolf; E. Kimby; M.B. van 't Veer; A. Vranovsky; H. Holte; A. Hagenbeek

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

M.H.J. van Oers, M. van Glabbeke, L. Giurgea, R. Klasa, R.E. Marcus, M. Wolf, E. Kimby, M.B. van 't Veer, A. Vranovsky, H. Holte, A. Hagenbeek

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2853-2858
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	28
Issue number	17
Publication status	Published - 2010

Cite this

van Oers, M. H. J., van Glabbeke, M., Giurgea, L., Klasa, R., Marcus, R. E., Wolf, M., Kimby, E., van 't Veer, M. B., Vranovsky, A., Holte, H., & Hagenbeek, A. (2010). Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. Journal of Clinical Oncology, 28(17), 2853-2858.

@article{c244b0b63d254deca9c9d3c22eeec8cb,

title = "Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.",

author = "{van Oers}, M.H.J. and {van Glabbeke}, M. and L. Giurgea and R. Klasa and R.E. Marcus and M. Wolf and E. Kimby and {van 't Veer}, M.B. and A. Vranovsky and H. Holte and A. Hagenbeek",

year = "2010",

language = "English",

volume = "28",

pages = "2853--2858",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "17",

}

van Oers, MHJ, van Glabbeke, M, Giurgea, L, Klasa, R, Marcus, RE, Wolf, M, Kimby, E, van 't Veer, MB, Vranovsky, A, Holte, H & Hagenbeek, A 2010, 'Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.', Journal of Clinical Oncology, vol. 28, no. 17, pp. 2853-2858.

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. / van Oers, M.H.J.; van Glabbeke, M.; Giurgea, L. et al.
In: Journal of Clinical Oncology, Vol. 28, No. 17, 2010, p. 2853-2858.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

AU - van Oers, M.H.J.

AU - van Glabbeke, M.

AU - Giurgea, L.

AU - Klasa, R.

AU - Marcus, R.E.

AU - Wolf, M.

AU - Kimby, E.

AU - van 't Veer, M.B.

AU - Vranovsky, A.

AU - Holte, H.

AU - Hagenbeek, A.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0732-183X

VL - 28

SP - 2853

EP - 2858

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 17

ER -